Search Results - "Mastroianni, C."

A hybrid classical-quantum approach to speed-up Q-learning by Sannia, A., Giordano, A., Gullo, N. Lo, Mastroianni, C., Plastina, F.

“…We introduce a classical-quantum hybrid approach to computation, allowing for a quadratic performance improvement in the decision process of a learning agent…”
Get full text

Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study by Oliva, Alessandra, Liguori, L, Covino, S, Petrucci, F, Cogliati-Dezza, F, Curtolo, A, Savelloni, G, Comi, M, Sacco, F, Ceccarelli, G, Viscido, A, Alessandri, F, Raponi, G, Pugliese, F, Mastroianni, CM, Venditti, M

“…Background We assessed the clinical effectiveness of cefiderocol (CFDC) in comparison with colistin (COL) for the treatment of carbapenem-resistant…”
Get full text

Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study by Oliva, A., Curtolo, A., Volpicelli, L., Cancelli, F., Borrazzo, C., Cogliati Dezza, F., Marcelli, G., Gavaruzzi, F., Di Bari, S., Ricci, P., Turriziani, O., Mastroianni, C. M., Venditti, M.

“…Background We evaluated clinical features and risk factors for mortality in patients with haematological malignancies and COVID-19. Methods Retrospective,…”
Get full text

Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection by Cogliati Dezza, F., Oliva, A., Cancelli, F., Savelloni, G., Valeri, S., Mauro, V., Calabretto, M., Russo, G., Venditti, M., Turriziani, O., Mastroianni, C.M.

“…•Prevention of transmission is crucial to reduce the global spread of SARS-CoV-2.•The kinetic of viral shedding in COVID-19 is still unknown.•It is of urgent…”
Get full text

Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature by Oliva, Alessandra, Siccardi, G., Migliarini, A., Cancelli, F., Carnevalini, M., D’Andria, M., Attilia, I., Danese, V. C., Cecchetti, V., Romiti, R., Ceccarelli, G., Mastroianni, C. M., Palange, P., Venditti, M.

“…Introduction The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays,…”
Get full text

Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study by Oliva, A., Curtolo, A., Volpicelli, L., Cancelli, F., Borrazzo, C., Cogliati Dezza, F., Marcelli, G., Gavaruzzi, F., Di Bari, S., Ricci, P., Turriziani, O., Mastroianni, C. M., Venditti, M.

Get full text

Molecular diagnosis of SARS-CoV-2 in seminal fluid by Paoli, D., Pallotti, F., Nigro, G., Mazzuti, L., Hirsch, M. N., Valli, M. B., Colangelo, S., Mastroianni, C. M., Antonelli, G., Lenzi, A., Turriziani, O., Lombardo, F.

“…Purpose Due to relevant repercussions on reproductive medicine, we aimed to evaluate feasibility of RT-PCR as a detection method of SARS-CoV-2 RNA in seminal…”
Get full text

Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study by Paoli, D., Pallotti, F., Anzuini, A., Bianchini, S., Caponecchia, L., Carraro, A., Ciardi, M. R., Faja, F., Fiori, C., Gianfrilli, D., Lenzi, A., Lichtner, M., Marcucci, I., Mastroianni, C. M., Nigro, G., Pasculli, P., Pozza, C., Rizzo, F., Salacone, P., Sebastianelli, A., Lombardo, F.

“…Purpose While SARS-CoV-2 infection appears not to be clinically evident in the testes, indirect inflammatory effects and fever may impair testicular function…”
Get full text

Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents by Pavone, P., Tieghi, T., d'Ettorre, G., Lichtner, M., Marocco, R., Mezzaroma, I., Passavanti, G., Vittozzi, P., Mastroianni, C.M., Vullo, V.

“…Association between hepatitis C virus (HCV) infection and diabetes has been widely postulated. Little is known about the effect of direct-acting antiviral…”
Get full text

Opinion: Learning as we go: Lessons from the publication of Facebook's social-computing research by Kahn, Jeffrey P., Vayena, Effy, Mastroianni, Anna C.

Get full text

In vitro effect of anti‐human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells by Rossi, R., Lichtner, M., De Rosa, A., Sauzullo, I., Mengoni, F., Massetti, A. P., Mastroianni, C. M., Vullo, V.

“…Summary Compounds targeting the chemokine receptor CCR5 have recently been approved for treatment of human immunodeficiency virus (HIV) infection. Given the…”
Get full text

Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission by Oliva, A., Ceccarelli, G., Borrazzo, C., Ridolfi, M., D.’Ettorre, G., Alessandri, F., Ruberto, F., Pugliese, F., Raponi, G. M., Russo, A., Falletta, A., Mastroianni, C. M., Venditti, M.

“…Background Little is known in distinguishing clinical features and outcomes between coronavirus disease-19 (COVID-19) and influenza (FLU). Materials/methods…”
Get full text

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? by Belvisi, V., Del Borgo, C., Vita, S., Redaelli, P., Dolce, P., Pacella, D., Kertusha, B., Carraro, A., Marocco, R., De Masi, M., Mastroianni, C., Lichtner, M., Cosentino, C., Alibardi, L., De Marchis, L., Aiuti, M., Carraturo, A., Parrocchia, S., Mecozzi, A., De Meo, A.

Get full text

In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value by Oliva, A, Scorzolini, L, Cipolla, A, Mascellino, M T, Cancelli, F, Castaldi, D, D'Abramo, A, D'Agostino, C, Russo, G, Ciardi, M R, Mastroianni, C M, Vullo, V

“…We evaluated the in vitro activity of different antimicrobial combinations with and without colistin against 39 carbapenem-resistant Klebsiella pneumoniae…”
Get full text

Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae by Oliva, A., Gizzi, F., Mascellino, M.T., Cipolla, A., D'Abramo, A., D'Agostino, C., Trinchieri, V., Russo, G., Tierno, F., Iannetta, M., Mastroianni, C.M., Vullo, V.

“…Available therapeutic options against carbapenem-resistant Klebsiella pneumoniae (CR-Kp) are limited because of the high level of resistance to other…”
Get full text

Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) by Oliva, A, Scorzolini, L, Castaldi, D, Gizzi, F, De Angelis, M, Storto, M, D’Abramo, A, Aloj, F, Mascellino, M.T, Mastroianni, C.M, V, Vullo

Get full text

The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study by La Torre, G, Marte, M, Massetti, A P, Carli, S M, Romano, F, Mastroianni, C M, Minorenti, M, Alessandri, F, Ajassa, C, Fusconi, M, De Vincentiis, M, de Meo, D, Villani, C, Cardi, M, Pugliese, F

“…SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has been identified in China as responsible for viral pneumonia, now called COVID-19 (Coronavirus…”
Get more information

Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes by Falcone, M., Tiseo, G., Iraci, F., Raponi, G., Goldoni, P., Delle Rose, D., Santino, I., Carfagna, P., Murri, R., Fantoni, M., Fontana, C., Sanguinetti, M., Farcomeni, A., Antonelli, G., Aceti, A., Mastroianni, C., Andreoni, M., Cauda, R., Petrosillo, N., Venditti, M.

“…Our objective was to evaluate factors associated with recurrence in patients with 027+ and 027– Clostridium difficile infection (CDI). Patients with CDI…”
Get full text

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C by Di Maio, Velia Chiara, Barbaliscia, Silvia, Teti, Elisabetta, Fiorentino, Gianluca, Milana, Martina, Paolucci, Stefania, Pollicino, Teresa, Morsica, Giulia, Starace, Mario, Bruzzone, Bianca, Gennari, William, Micheli, Valeria, Yu La Rosa, Katia, Foroghi, Luca, Calvaruso, Vincenza, Lenci, Ilaria, Polilli, Ennio, Babudieri, Sergio, Aghemo, Alessio, Raimondo, Giovanni, Sarmati, Loredana, Coppola, Nicola, Pasquazzi, Caterina, Baldanti, Fausto, Parruti, Giustino, Perno, Carlo Federico, Angelico, Mario, Craxì, Antonio, Andreoni, Massimo, Ceccherini‐Silberstein, Francesca, Andreone, P, Aragri, M, Bertoli, A, Boeri, E, Brancaccio, G, Brunetto, M, Callegaro, AP, Cenderello, G, Cento, V, Ciaccio, A, Ciancio, A, Cuomo, N, De Santis, A, Di Biagio, A, Di Marco, V, Di Perri, G, Di Stefano, MA, Gaeta, GB, Ghisetti, V, Gulminetti, R, Lampertico, P, Landonio, S, Lichtner, M, Lleo, A, Maida, I, Marenco, S, Masetti, C, Mastroianni, C, Minichini, C, Milano, E, Monno, L, Novati, S, Pace Palitti, V, Paternoster, C, Pellicelli, A, Pieri, A, Puoti, M, Rizzardini, G, Ruggiero, T, Rossetti, B, Sangiovanni, V, Santantonio, T, Taliani, G, Toniutto, P, Vullo, V., Zazzi, M

“…Aim This study aimed to investigate the role of resistance‐associated substitutions (RASs) to direct‐acting‐antivirals (DAAs) in HCV genotype 3 (GT3). Methods…”
Get full text

Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis by Sauzullo, I., Mengoni, F., Marocco, R., Potenza, C., Skroza, N., Tieghi, T., Lichtner, M., Vullo, V., Mastroianni, C.M.

“…Summary Background Screening for latent tuberculosis infection (LTBI) is mandatory in patients with psoriasis prior to starting on tumour necrosis factor (TNF)…”
Get full text